34586-44-2Relevant articles and documents
New FBPase inhibitors for diabetes
-
Page/Page column 15, (2008/06/13)
Compounds of formula as well as pharmaceutically acceptable salts and esters thereof, wherein R1 to R3 have the significance given in the application and which can be used in the form of pharmaceutical compositions.
NATHAN-BAKER EFFECTS IN THE HETEROGENEOUS SULFONATION OF ALKYLBENZENES
Krylov, E. N.,Khokhlova, S. G.
, p. 341 - 343 (2007/10/02)
-